These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 35580699)
1. KDM2B mediates the Wnt/β-catenin pathway through transcriptional activation of PKMYT1 via microRNA-let-7b-5p/EZH2 to affect the development of non-small cell lung cancer. Zhang X; Yin Z; Li C; Nie L; Chen K Exp Cell Res; 2022 Aug; 417(2):113208. PubMed ID: 35580699 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of microRNA let-7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer. Kuang Y; Xu H; Lu F; Meng J; Yi Y; Yang H; Hou H; Wei H; Su S Cancer Sci; 2021 Jan; 112(1):231-242. PubMed ID: 33091189 [TBL] [Abstract][Full Text] [Related]
3. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway. He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993 [TBL] [Abstract][Full Text] [Related]
4. The KDM2B- let-7b -EZH2 axis in myelodysplastic syndromes as a target for combined epigenetic therapy. Karoopongse E; Yeung C; Byon J; Ramakrishnan A; Holman ZJ; Jiang PY; Yu Q; Deeg HJ; Marcondes AM PLoS One; 2014; 9(9):e107817. PubMed ID: 25225797 [TBL] [Abstract][Full Text] [Related]
5. Lysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cells. Tzatsos A; Paskaleva P; Lymperi S; Contino G; Stoykova S; Chen Z; Wong KK; Bardeesy N J Biol Chem; 2011 Sep; 286(38):33061-9. PubMed ID: 21757686 [TBL] [Abstract][Full Text] [Related]
6. Repression of lncRNA-SVUGP2 mediated by EZH2 contributes to the development of non-small cell lung cancer via brisking Wnt/β-catenin signal. Wei S; Liu J; Li X; Liu X Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3400-3409. PubMed ID: 31401873 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer. Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of EZH2 genes targeting RUNX3 affects proliferation, invasion, and metastasis of human colon cancer cells by Wnt/β-catenin signaling pathway. Liang G; Han L; Qu M; Xue J; Xu D; Wu X; Lu Y Aging (Albany NY); 2023 Dec; 15(23):13655-13668. PubMed ID: 38048186 [TBL] [Abstract][Full Text] [Related]
9. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer. Zhang Z; Yang Y; Zhang X Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645 [TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling. Ma J; Zhao D; Yu D; Song W; Yang X; Yin H Cancer Med; 2023 Jun; 12(11):12653-12667. PubMed ID: 37081781 [TBL] [Abstract][Full Text] [Related]
11. KDM2B is involved in the epigenetic regulation of TGF-β-induced epithelial-mesenchymal transition in lung and pancreatic cancer cell lines. Wanna-Udom S; Terashima M; Suphakhong K; Ishimura A; Takino T; Suzuki T J Biol Chem; 2021; 296():100213. PubMed ID: 33779563 [TBL] [Abstract][Full Text] [Related]
12. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma. Chen Q; Zheng PS; Yang WT Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879 [TBL] [Abstract][Full Text] [Related]
13. LncRNA DLG5-AS1 facilitates breast cancer cell proliferation and invasion by promoting EZH2-mediated transcriptional silencing of SFRP1. Cai Y; Liu Y; Sun Y; Ren Y Arch Biochem Biophys; 2024 Jun; 756():110018. PubMed ID: 38677505 [TBL] [Abstract][Full Text] [Related]
14. MiR-346-5p promotes colorectal cancer cell proliferation in vitro and in vivo by targeting FBXL2 and activating the β-catenin signaling pathway. Pan S; Wu W; Ren F; Li L; Li Y; Li W; Wang A; Liu D; Dong Y Life Sci; 2020 Mar; 244():117300. PubMed ID: 31953162 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of PKMYT1 indicates the poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer via activation of Notch signal pathway. Sun QS; Luo M; Zhao HM; Sun H Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4210-4219. PubMed ID: 31173292 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2. Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978 [TBL] [Abstract][Full Text] [Related]
17. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling. Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of long intergenic non-coding RNA LINC00326 inhibits non-small cell lung carcinoma progression by blocking Wnt/β-catenin pathway through modulating the miR-657/dickkopf WNT signaling pathway inhibitor 2 axis. Zhang Y; Yuan J; Guo M; Xiang R; Xie T; Zhuang X; Dai W; Li Q; Lai Q Biol Direct; 2023 Feb; 18(1):3. PubMed ID: 36747258 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNASEH1-AS1 exacerbates the progression of non-small cell lung cancer by acting as a ceRNA to regulate microRNA-516a-5p/FOXK1 and thereby activating the Wnt/β-catenin signaling pathway. Zhang C; Huang J; Lou K; Ouyang H Cancer Med; 2022 Apr; 11(7):1589-1604. PubMed ID: 35166053 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of lysine (K)-specific demethylase 2B KDM2B inhibits glycolysis and induces autophagy in lung squamous cell carcinoma cells by regulating the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway. Xie Z; Li H; Zang J Bioengineered; 2021 Dec; 12(2):12227-12235. PubMed ID: 34783291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]